Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate

13 Dec 2019

Abstract excerpt

SCOPE: Recent evidences demonstrate that abnormal gut microbiota (GM) might be involved in the pathogenesis of Alzheimer's disease (AD). However, the role of probiotics in preventing AD by regulating GM-gut-brain axis remains unclear. Here, the anti-neuroinflammatory effect and its mechanism of probiotic Clostridium butyricum (CB) against AD is investigated by regulating GM-gut-brain axis. METHODS AND RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Gut microbiota and health
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31835282
DOI: 10.1002/mnfr.201900636

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites ButyratePMID 31835282Read ↗

Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic PerspectiveSemantic proximity Read ↗

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical ModelsSemantic proximity Read ↗

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse modelSemantic proximity Read ↗

Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational TherapeuticsSemantic proximity Read ↗

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeuticsSemantic proximity Read ↗

The role of gut microbiota in pathogenesis of Alzheimer's diseaseSemantic proximity Read ↗

The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic FormulationsSemantic proximity Read ↗

The gut microbiota affects amyloid deposition in Alzheimer’s disease models by suppressing immune-mediated Aβ clearanceSemantic proximity Read ↗

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to TreatmentSemantic proximity Read ↗

Gut-derived β-amyloid: Likely a centerpiece of the gut–brain axis contributing to Alzheimer’s pathogenesisSemantic proximity Read ↗

Modulation of Alzheimer’s Disease Brain Pathology in Mice by Gut Bacterial Deletion: The Role of Il-17a and Microglial MyD88Semantic proximity Read ↗

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.